Pathogen inactivation and transfusion
Reviewer: Huy Phu Pham, M.D. (see Reviewers page)
Revised: 6 November 2011, last major update September 2011
Copyright: (c) 2007-2011, PathologyOutlines.com, Inc.
● Additional layer of protection from known and unknown infectious agents (Semin Hematol 2007;44:32),
such as leukoreduction (filtration), chemicals and mechanical agents (heat, radiation, fractionation)
● Techniques may damage blood products or have their own side effects
● Examples: Methylene blue for fresh frozen plasma (Vox Sang 2007;92:319), photochemical treatment with amotosalen and ultraviolet A for parvovirus B19 (Transfusion 2007;47:1062), S-303 for red cells (Transfusion 2006;46:1778)
● Arch Pathol Lab Med 2007;131:719, Transfus Apher Sci 2006;35:189, Transfus Apher Sci 2006;35:83 (plasma), Best Pract Res Clin Haematol 2006;19:205
End of Transfusion Medicine > Tranfusion-transmitted disease > Pathogen inactivation and transfusion
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).